Defined Tumor Antigen-Specific T Cells Potentiate Personalized TCR-T Cell Therapy and Prediction of Immunotherapy Response

T cells engineered with T cell receptors (TCRs) from naturally occurring tumor antigen-specific T cells in a patient will target personal tumor-specific antigens in their tumor.